Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
0.6720
-0.0180 (-2.61%)
Aug 18, 2026, 11:08 AM EDT - Market open
Aprea Therapeutics Stock Forecast
APRE's stock price has decreased by -59.17% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 4 analysts polled by S&P Global, Aprea Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $3.55. The average 1-year stock price forecast is 428.27% higher than the current stock price, while the lowest is $1.20 (+78.57%) and the highest is $5.00 (+644.05%).
Price Target: $3.55 (+428.27%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Aprea Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Buy Reiterates $5 | Buy | Reiterates | $5 | +644.05% | Aug 14, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $5 | Buy | Reiterates | $5 | +644.05% | Aug 13, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $1.2 | Buy | Reiterates | $1.2 | +78.57% | Aug 13, 2026 |
| Wedbush | Wedbush | Buy Reiterates $7 → $6 | Buy | Reiterates | $7 → $6 | +792.86% | May 14, 2026 |
Financial Forecast
Revenue This Year
408.50K
from 285.76K
Increased by 42.95%
Revenue Next Year
1.13M
from 408.50K
Increased by 176.99%
EPS This Year
-0.33
from -1.93
EPS Next Year
-0.53
from -0.33
EPS and Forward PE are based on non-GAAP adjusted numbers.